Remarkably, epigenetic interventions using DNMT inhibitors significantly enhanced the radiosensitivity of resistant oral cancer cells, in vivo. Our results together with previous observations [30-31] suggest that concomitant treatment of DNA-demethylating agents and radiotherapy is a new treatment direction for this aggressive malignancy. Here, DNMT1 is linked to lip and oral cavity carcinoma.